HFE rs1800441: Understanding the H63D Variant
The rs1800441 variant, commonly known as H63D, is a genetic change in the HFE gene. It is associated with altered iron metabolism, though it typically results in only mild or non-penetrant changes in iron levels.
What each genotype means
Typical iron regulation
This genotype represents the most common form of the HFE gene, often referred to as the wild-type. Individuals with this profile do not carry the H63D variant and are expected to have standard iron metabolism related to this specific genetic locus. Please consult with a healthcare provider if you have concerns regarding your iron levels or symptoms of iron overload.
This is the most common genotype globally, found in the vast majority of the population.
H63D carrier
Carrying one copy of the H63D variant is very unlikely to cause clinical iron overload on its own. While some studies suggest a potential for mild variations in iron markers, most carriers remain asymptomatic throughout their lives. You should discuss any concerns about iron status or family history with your clinician.
The H63D allele is common in European populations, with carrier frequencies often ranging between 10% and 20%.
H63D homozygous
Individuals with two copies of the H63D variant have a much lower risk of developing clinically significant iron overload compared to other HFE-related genotypes. While some research indicates a potential for mild, non-penetrant ferritin elevation, the clinical penetrance is considered very low. It is recommended to discuss your iron status and any relevant symptoms with a healthcare professional.
This genotype is relatively uncommon, occurring at lower frequencies than the heterozygous state in most populations.
What is the rs1800441 Variant?
The rs1800441 variant, frequently referred to as H63D, is a single nucleotide polymorphism (SNP) located within the HFE gene. In this specific genetic change, the amino acid histidine is replaced by aspartic acid at position 63 of the HFE protein. This variant is one of the most studied changes in the HFE gene, which provides instructions for making a protein that regulates iron absorption in the body. While the HFE gene is most famously associated with hereditary hemochromatosis, the H63D variant is distinct from the more severe C282Y mutation. Researchers track this variant to understand how subtle changes in protein structure might influence the body's ability to manage iron levels over a lifetime. Because it is a common variant, it has been the subject of extensive population-based studies aimed at determining its clinical impact on health.
The Role of the HFE Gene
The HFE gene plays a critical role in systemic iron homeostasis. The protein it produces helps regulate the interaction between the transferrin receptor and transferrin, which is the primary protein responsible for transporting iron through the bloodstream. By modulating this interaction, the HFE protein helps the body sense iron levels and adjust intestinal iron absorption accordingly. When the HFE gene functions normally, it prevents the body from absorbing too much iron. Mutations or variants in this gene can disrupt this regulatory mechanism, potentially leading to increased iron absorption. While severe mutations can cause hereditary hemochromatosis, a condition characterized by dangerous iron overload, the H63D variant is generally considered to have a much milder effect on this process. Understanding the HFE gene's function is essential for interpreting how variants like rs1800441 may influence an individual's iron profile.
Research and Clinical Associations
Scientific research into the H63D variant has yielded mixed results regarding its clinical significance. Studies have shown that H63D homozygotes may experience elevated mean ferritin levels, but documented cases of significant iron overload are relatively rare. The penetrance of this variant—the likelihood that a person with the genotype will show clinical symptoms—is considered low. Some research has explored potential links between H63D and other conditions, such as early-onset arthropathy or hypertension, but these findings are often inconsistent or lack strong evidence. Because many studies have been based on clinical samples rather than the general population, there is a risk of selection bias, making it difficult to generalize the findings. Current consensus suggests that while H63D is a marker for altered iron metabolism, it is rarely the sole cause of severe clinical iron overload in the absence of other genetic or environmental factors.
Population Frequency
The frequency of the rs1800441 variant varies significantly across different ancestral groups. In European populations, the minor allele frequency is typically observed between 0.10 and 0.16, making it a relatively common genetic variation. In contrast, the variant is less frequent in East Asian populations, where the minor allele frequency is generally reported between 0.02 and 0.05. These differences highlight the importance of considering ancestry when interpreting genetic data. Because the variant is common in many populations, it is frequently identified in routine genetic testing. However, its high prevalence in the general population further supports the observation that carrying the variant does not automatically lead to clinical disease. Researchers continue to study these frequency patterns to better understand the evolutionary history and distribution of the HFE gene across the globe.
Interpreting Your Genetic Information
If you have received information about your HFE rs1800441 status, it is important to understand that this is not a medical diagnosis. The presence of the H63D variant does not guarantee that you will develop iron-related health issues. Many individuals with this variant maintain normal iron levels throughout their lives. Genetic testing provides only one piece of the puzzle; clinical iron status is determined by a combination of genetics, diet, and other environmental factors. You cannot use this information to diagnose yourself or to make decisions about medical treatments, such as iron supplementation or phlebotomy. If you are concerned about your iron levels or have questions about your genetic results, the most appropriate step is to discuss them with a healthcare professional. A doctor can order blood tests, such as serum ferritin and transferrin saturation, to accurately assess your iron status and provide personalized medical guidance.
How common is this variant?
The minor allele frequency for rs1800441 is approximately 0.10 to 0.16 in European populations and 0.02 to 0.05 in East Asian populations.
Frequently asked questions
Does having the H63D variant mean I have hemochromatosis?
No, having the H63D variant does not mean you have hereditary hemochromatosis. While it is a variant in the HFE gene, it is generally associated with only mild changes in iron levels and rarely causes the severe iron overload seen in other HFE-related conditions.
Should I avoid iron-rich foods if I have the H63D variant?
There is no standard medical recommendation for individuals with the H63D variant to avoid iron-rich foods. You should discuss your specific iron levels and dietary needs with your doctor or a registered dietitian before making significant changes to your diet.
Is the H63D variant the same as the C282Y mutation?
No, H63D and C282Y are different variants within the HFE gene. C282Y is more strongly associated with the risk of developing hereditary hemochromatosis, whereas H63D is considered to have a much lower clinical impact.
How can I check if my iron levels are healthy?
The only way to accurately assess your iron levels is through blood tests ordered by a healthcare provider. Common tests include serum ferritin and transferrin saturation, which provide a clear picture of your body's iron storage and transport.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800441?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HFE
The Ser65Cys missense polymorphism in HFE linked to mild systemic iron regulation changes and downstream impacts on hypogonadotropic reproductive function.
The C282Y missense variant in HFE is the primary genetic cause of hereditary hemochromatosis, leading to iron overload.
Common HFE missense variant H63D associated with hereditary hemochromatosis and mild iron overload risk.
HFE p.His63Asp (H63D) variant contributing to hereditary hemochromatosis risk, especially in compound heterozygosity with C282Y.
Coding variant (p.Val162Met) in the homeostatic iron regulator gene studied alongside classical hemochromatosis variants.
Known as HFE S65C (c.193A>T), this missense variant is associated with mild variations in transferrin saturation and iron accumulation, often evaluated alongside C282Y and H63D.